Ludwig Enterprises, Inc.

Equities

LUDG

US54973P4019

Market Closed - OTC Markets Other stock markets 01:13:50 01/06/2024 am IST			5-day change	1st Jan Change
0.21 ^USD	+11.70%		+5.00%	+54.98%

20/05	Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/04	Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Ludwig Enterprises, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023

August 18, 2023 at 03:46 pm IST

Ludwig Enterprises, Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was USD 1.56 million compared to USD 0.276594 million a year ago.

Latest news about Ludwig Enterprises, Inc.

Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	21/05	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	17/04	CI
Ludwig Enterprises Inc. Enters Booming Artificial Intelligence Cancer Screening Market with Its Non-Invasive Cancer Diagnostics Testing Kit, Launching Within 2024	19/03	CI
Ludwig Enterprises Inc. Announces Patent Filing for Breakthrough in Identifying Mrna Genes Associated with Certain Cancers	06/03	CI
Ludwig Enterprises, Inc. announced that it has received $0.04 million in funding	12/02	CI
Ludus Enterprises, Inc. Receives Continuing Review Approval on Planned Clinical Study from Advarra IRB, Columbia, MD	31/01	CI
Ludwig Enterprises, Inc. Announces Executive Changes	02/12	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11	CI
Ludwig Enterprises, Inc. Appoints Scott Silverman as Chief Financial Officer	16/11	CI
Ludwig Enterprises, Inc. Announces Marvin S. Hausman as Chief Executive Officer	19/23/19	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	18/23/18	CI
Ludwig Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	21/23/21	CI
Ludwig Enterprises Announces Launches of New Nutraceutical and Strategic Marketing Plan	25/23/25	CI
Ludwig Enterprises Launches Nugenea, Groundbreaking Nutraceutical to Fight Inflammation	12/23/12	CI
Ludwig Enterprises, Inc. Auditor Raises 'Going Concern' Doubt	15/23/15	CI
Ludwig Enterprises, Inc. Receives Institutional Review Board Approval on Bladder Cancer Study	03/23/03	CI
Ludwig Enterprises Files A Patent That Could Be A Major Technology Breakthrough in Healthcare	22/22/22	CI
Ludwig Enterprises and Emerson Urology Associates Plan Bladder Cancer BCG Immunotherapy Study	20/22/20	CI
Ludwig Enterprises, Inc. Appoints Dr. Kyle Ambert to Scientific Advisory Board	21/22/21	CI
Ludwig Enterprises, Inc. Appoints Anne Blackstone as Director	12/22/12	CI
Ludwig Enterprises, Inc. Appoints Anne Blackstone as Chief Executive Officer	12/22/12	CI
Ludwig Enterprises, Inc. acquired Direct Mortgage Investors, Inc.	19/19/19	CI
Ludwig Enterprises Inc. acquired Floss Publishing, Inc.	23/14/23	CI
Ludwig Enterprises, Inc., Opens Acquisition Talks With Floss Publishing, Inc.	03/14/03	CI
Ludwig Enterprises Inc. Announces Joint Venture Agreement with Worthington Financial Services, Inc	17/12/17	CI

Chart Ludwig Enterprises, Inc.

Duration

Period

More charts

Company Profile

Sector

More about the company

Income Statement Evolution

More financial data